Meril MERISCREEN HIV 1-2 WB is a professional in-vitro diagnostic rapid test designed for the qualitative detection of antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in human whole blood, serum or plasma specimens.
Manufactured by Meril Diagnostics Pvt. Ltd., MERISCREEN HIV 1-2 WB uses a rapid immunochromatographic test format and is intended for use by appropriately trained healthcare and laboratory professionals in accordance with the manufacturer's current Instructions for Use (IFU) and applicable HIV-testing guidelines.
This listing is for the 50-test pack, manufacturer product code HVWRPD-06.
Professional IVD use only. This product is not intended for unsupervised self-testing or self-diagnosis.
| Brand | Meril Diagnostics |
| Product | MERISCREEN HIV 1-2 WB |
| Manufacturer Product Code | HVWRPD-06 |
| Test Category | HIV Rapid Diagnostic Test |
| Detection | Antibodies to HIV-1 and HIV-2 |
| Specimen | Whole Blood / Serum / Plasma |
| Test Method | Rapid Immunochromatographic Assay |
| Result Type | Qualitative |
| Pack Size | 50 Tests |
| Result Reading | 20 minutes; do not interpret after 30 minutes |
| Storage | 2–30°C; follow current manufacturer IFU |
| Intended User | Trained healthcare and laboratory professionals |
| Use | Professional In-Vitro Diagnostic Use |
MERISCREEN HIV 1-2 WB is designed to detect antibodies associated with HIV-1 and HIV-2 infection.
The assay is a qualitative screening test. Results are interpreted according to the manufacturer's current test procedure and applicable institutional or national HIV-testing algorithm.
It should not be confused with an HIV antigen/antibody fourth-generation assay. MERISCREEN HIV 1-2 WB is an HIV antibody rapid test.
According to manufacturer information, MERISCREEN HIV 1-2 WB can be used with:
Specimen collection, preparation and testing should be performed by trained personnel using the manufacturer's current Instructions for Use.
The manufacturer's published test protocol specifies:
Important: This is only a general product overview. Laboratory personnel must use the current manufacturer-supplied pack insert and SOP applicable to the specific lot being tested.
MERISCREEN HIV 1-2 WB is designed to provide qualitative test-line patterns that must be interpreted according to the manufacturer's current IFU.
Possible manufacturer-described interpretations include:
An invalid test must not be reported as a patient result. Testing should be repeated in accordance with the manufacturer's instructions and laboratory procedures.
No. A reactive rapid HIV screening result should not by itself be treated as a final diagnosis of HIV infection.
Reactive, discordant or otherwise clinically significant results must be managed according to the applicable national HIV-testing algorithm, institutional protocol and professional medical guidance.
Similarly, a non-reactive result does not necessarily exclude very recent HIV infection because antibodies may not yet be detectable during the early period following infection.
The Meril MERISCREEN HIV 1-2 WB 50-test laboratory pack is intended for professional environments such as:
It is not intended to replace medical consultation or professional laboratory interpretation.
Store the kit within the manufacturer's specified temperature range of 2–30°C and follow all storage, humidity, packaging and handling requirements printed on the current product label and pack insert.
Explore the complete Rapid Test Kits collection at Microsidd for HIV and other professional infectious-disease rapid diagnostic products.
For a broader explanation of HIV rapid-test formats, see the Microsidd HIV Test Kit Comparison Guide.
Laboratories using an ELISA workflow can also review the Meril MeriLisa HIV 1-2 Gen 3 ELISA Kit – 96 Tests.
MERISCREEN HIV 1-2 WB is a professional rapid in-vitro diagnostic test manufactured by Meril Diagnostics for qualitative detection of antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma.
This listing contains 50 tests.
The Meril manufacturer product code for the 50-test configuration is HVWRPD-06.
Yes. The assay is designed for qualitative detection of antibodies associated with both HIV-1 and HIV-2.
The manufacturer specifies human whole blood, serum and plasma specimens.
The manufacturer's published protocol instructs users to interpret the result at 20 minutes and not to interpret the test after 30 minutes.
No. MERISCREEN HIV 1-2 WB is an HIV-1/HIV-2 antibody rapid test. A fourth-generation HIV assay is designed to incorporate antigen detection in addition to HIV antibody detection.
This product is intended for trained professional use and should not be presented as an unsupervised consumer self-test.
No. A reactive screening result must be managed and confirmed according to the applicable HIV-testing algorithm and interpreted by qualified healthcare professionals.
The documented storage range is 2–30°C. Always verify the label and current Instructions for Use supplied with the specific product lot.
Important: On 16 March 2026, the World Health Organization issued Information Notice for IVD Users 2026/01 concerning specified rapid diagnostic products manufactured at certain Meril Diagnostics manufacturing sites, including MERISCREEN HIV 1-2 WB.
Customers and professional users should review the latest applicable manufacturer communications, national regulatory guidance and institutional procurement requirements before procurement or use. Product acceptance, deployment and continued use should follow applicable regulatory and professional requirements.
This product is non-returnable and non-exchangeable.
Please verify the manufacturer, product name, product code, test parameter, specimen type, pack size, storage requirements and intended professional use before ordering.
Genuine cases involving an incorrect product received will be handled separately according to Microsidd.com's applicable policies and applicable law.
An original, continuous, unedited and uncut unboxing video should be retained for any claim regarding an incorrect product received.
MERISCREEN HIV 1-2 WB is intended for professional in-vitro diagnostic use. Testing should be performed by appropriately trained personnel using the manufacturer's current Instructions for Use, appropriate controls, laboratory SOPs and applicable national or institutional HIV-testing guidelines.
Information on this product page is provided for product identification and professional educational purposes and does not replace the manufacturer's Instructions for Use, clinical judgment, confirmatory testing requirements or applicable regulatory guidance.
| Specification name | Specification Value |
|---|---|
| Product certifications & standards | CE certified, CDSCO, ISO |
| Test method | Point-of-care test |
| Test sample | Blood |
